Zacks.com on MSN4d
GSK Gets EC Nod for Liquid Version of Meningococcal Vaccine Menveo
GSK plc GSK announced that the European Commission (EC) has approved a single-vial, fully liquid presentation of its ...
GlobalData on MSN4d
EC approves GSK’s Menveo vaccine presentation for IMD
The EC has granted approval for presentation of GSK's Menveo vaccine (MenACWY) for invasive meningococcal disease (IMD).
PMLiVE3d
GSK granted EC approval for meningococcal disease vaccine Menveo
GSK’s fully liquid presentation of its meningococcal vaccine Menveo has been approved by the European Commission (EC) to ...
Daily3d
GSK fully liquid Menveo meningococcal vaccine approved by European Commission
London: GSK plc has announced that the European Commission (EC) has approved a single-vial, fully liquid presentation of ...
The Pharma Letter5d
EC nod for GSK’s Menveo meningococcal vaccine
The European Commission (EC) has approved a single-vial, fully liquid presentation of Menveo (meningococcal Group A, C, W-135 ...
GSK's liquid meningitis vaccine approved by EU regulators
GSK's liquid meningitis vaccine Menveo has been approved by EU regulators, paving the way for a simpler vaccination process ...
Nasdaq4d
GSK Gets EC Nod for Liquid Version of Meningococcal Vaccine Menveo
GSK plc GSK announced that the European Commission (EC) has approved a single-vial, fully liquid presentation of its meningococcal vaccine, Menveo (MenACWY) for active immunization in children ...